[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hellp-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":36,"states":37},"HELLP Syndrome",4,3,[8,16,22,28],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06333652","Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders",[12],"Phase 2","RECRUITING","2026-08-26T02:18:09.641312Z","2026-05-05T02:43:27.444733Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06277661","The Mom and Infant Outcomes (MOMI) Study",[],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:28.840533Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT06377878","The Preeclampsia Registry",[],"2026-08-26T02:15:15.642947Z","2026-05-13T02:55:06.485227Z",{"nct_id":29,"title":30,"phases":31,"status":33,"updated_at":34,"content_modified":35},"NCT07220902","Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure",[32],"Phase 3","NOT_YET_RECRUITING","2026-08-26T02:18:15.214990Z","2026-05-05T02:43:29.502973Z",[],[]]